⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2460940 | 1.00 | — | — | |
| SCHEMBL6380368 | 0.93 | ALDH1A1 (0.48) | — | |
| SCHEMBL6261486 | 0.91 | ALDH1A1 (0.52) | — | |
| SCHEMBL6929123 | 0.91 | ALDH1A1 (0.52) | — | |
| SCHEMBL8896820 | 0.91 | ALDH1A1 (0.52) | — | |
| SCHEMBL9052189 | 0.85 | — | — | |
| SCHEMBL20641014 | 0.85 | — | — | |
| SCHEMBL6384594 | 0.85 | — | — | |
| Nitric Acid SCHEMBL8582389 | 0.81 | ALDH1A1 (0.40) | — | |
| SCHEMBL393470 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0748310-B1 | DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 1999-06-02 | — | — | EP | disclosed |
| US-5827881-A | ADMINISTERING FOR TREATMENT OF VIRAL DISEASES OR AS ANTIINFLAMMATORY AGENTS | ITALFARMACO S.P.A. (IT) | 1998-10-27 | — | — | US | disclosed |
| CN-1142222-A | Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity | ITALFARMACO SPA (IT) | 1997-02-05 | — | — | CN | disclosed |
| EP-0748310-A1 | DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO S.p.A. (IT) | 1996-12-18 | — | — | EP | disclosed |
| WO-1995023128-A1 | DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO S.P.A. (IT) | 1995-08-31 | — | — | WO | disclosed |